Yazılar

Volkswagen Faces Strikes Across Nine German Plants Amid Labor Dispute

/in /tarafından

Workers at nine Volkswagen (VW) car and component plants across Germany launched strikes on Monday, halting production lines in a growing dispute over wages and the future of the automaker’s operations in its home market.

Key Details of the Strike

  1. Affected Locations
    • The strikes affect key sites, including VW’s headquarters in Wolfsburg, and major plants in Hanover, Emden, Salzgitter, Brunswick, and the EV-focused Zwickau facility.
    • Demonstrations at Wolfsburg and Hanover are expected to draw thousands of workers.
  2. Duration and Escalation
    • The strikes are planned for several hours but could escalate into 24-hour or indefinite walkouts if an agreement isn’t reached in the next round of wage negotiations.
    • Employees at VW Sachsen GmbH sites, including Zwickau, will strike through Monday and Tuesday.
  3. Union Demands
    • IG Metall, the labor union leading the strike, has rejected Volkswagen’s demand for a 10% wage cut, citing concerns about the company’s approach to cost-saving.
    • The union proposed measures to save €1.5 billion ($1.6 billion), including the suspension of bonuses for 2025 and 2026, but Volkswagen dismissed the offer.
  4. Volkswagen’s Stance
    • The company argues that cost-cutting is essential to boost profits and defend its market share amid declining deliveries and profitability.
    • Volkswagen has taken steps to mitigate the strike’s impact by ensuring basic customer supply chains.
    • The automaker has warned of potential plant closures in Germany—an unprecedented move in its 87-year history.

Broader Context

  • Economic Pressures: Volkswagen faces a challenging market environment with declining demand and stiff competition, especially in the EV sector.
  • Union Concerns: IG Metall is pushing for a comprehensive long-term plan for all VW plants to safeguard jobs and ensure operational stability.

Next Steps

Negotiations between Volkswagen and IG Metall are set to resume on December 9. The union has vowed to resist any proposals that lack a robust strategy for maintaining operations across all German plants.

Implications

  • For Volkswagen: The strikes could exacerbate the company’s ongoing struggles with delivery schedules and profitability.
  • For the Auto Sector: The labor dispute highlights tensions within the industry as companies balance cost-cutting measures with the need to transition toward electric mobility.
  • For Workers: The outcome of the negotiations will significantly impact job security and wage structures for Volkswagen employees in Germany.

 

Activist Starboard Value Takes $1 Billion Stake in Pfizer, Eyes Turnaround with Former Executives’ Help

/in /tarafından

Activist investor Starboard Value has acquired a $1 billion stake in Pfizer, aiming to initiate changes at the pharmaceutical giant amidst its financial struggles, according to sources familiar with the situation. While Starboard’s exact strategy remains unclear, they have reportedly sought the expertise of former Pfizer executives Ian Read (former CEO) and Frank D’Amelio (ex-finance chief) to assist with the company’s turnaround efforts.

Starboard, led by Jeff Smith, is reportedly concerned about Pfizer’s recent shift away from its traditionally disciplined approach to cost management and investment in novel drugs under current CEO Albert Bourla. Pfizer’s revenue and free cash flow surged during the Covid-19 pandemic due to its successful vaccine rollout, but its stock has since underperformed, with shares down approximately 30% compared to 2019 levels. This downturn is partly attributed to Pfizer’s aggressive acquisition strategy, with nearly $70 billion spent on mergers and acquisitions since 2020, some of which have been met with skepticism by analysts.

One controversial acquisition was Pfizer’s $5 billion purchase of Global Blood Therapeutics, a deal that included the sickle cell drug Oxbryta, which the company recently pulled after modest sales of $300 million last year. Pfizer has played down the financial impact of this move, but it has raised concerns about the returns from recent acquisitions.

Return to Disciplined Leadership?

Former CEO Ian Read, who led Pfizer from 2010 to 2019, is remembered for doubling the company’s share value during his tenure by instituting a cost- and core-focused culture. Read’s leadership came at a time when Pfizer faced significant challenges, and his strategy of disciplined cost management and targeted investments helped turn the company around. Starboard appears to be advocating for a return to such leadership principles, contrasting them with the current trajectory under Bourla, which has focused more on acquisitions.

In response to financial pressure, Pfizer has already initiated cost-cutting measures, launching a $4 billion cost-reduction program and later expanding these efforts. Despite these steps, more than $100 billion in shareholder value has been lost since the height of the pandemic, reflecting the company’s ongoing difficulties.

Starboard’s Broader Strategy

Starboard Value, known primarily for its focus on the technology sector, is expanding its influence into the pharmaceutical industry with this Pfizer stake. The firm has been active in recent campaigns against companies like Autodesk, Salesforce, and Match Group, as well as challenging News Corp’s dual-class share structure.

This move marks a significant shift for Starboard, as it seeks to bring its activist playbook to Pfizer, a company that has historically weathered various challenges but now faces questions about its post-pandemic future. Starboard’s involvement signals a possible push for further restructuring at Pfizer, though the exact plans are yet to unfold.